Monoclonal Antibodies Targeting CGRP: A Novel Treatment in Vestibular Migraine

<i>Background</i>. Monoclonal antibodies (mAbs) directed against the calcitonin gene-related peptide (CGRP) or its receptor represented the first targeted and specialized approach to migraine prophylaxis. Nevertheless, they have been rarely considered in the treatment of vestibular migra...

Full description

Bibliographic Details

Published in:	Medicina
Main Authors:	Andrea Lovato, Caterina Disco, Andrea Frosolini, Daniele Monzani, Francesco Perini
Format:	Article
Language:	English
Published:	MDPI AG 2023-08-01
Subjects:	vestibular migraine migraine dizziness monoclonal antibodies nystagmus vertigo
Online Access:	https://www.mdpi.com/1648-9144/59/9/1560